publications
Publications
Selected Papers
- Jae-Yeol Joo, Katie Schaukowitch, Lukas Farbiak, Gokhul Kilaru, and
Tae-Kyung Kim Stimulus-specific combinatorial functionality of
neuronal c-fos enhancers. Nature Neuroscience 19(1):75-83 (2016)
- Katie Schaukowitch*, Jae-Yeol Joo*, Xihui Liu, Jonathan K. Watts, Carlos
Martinez, and Tae-Kyung Kim Enhancer RNA Facilitates NELF Release from
Immediate Early Genes. Molecular Cell 56(1):29-42 (2014). *Co-first
author This paper previewed by “eRNAs lure NELF from paused
polymerases” Molecular Cell 56(1):3-4 (2014)
- Sung-Hyun Kim+, Sumin Yang+, Key-Hwan Lim+, Euiseng Ko , Hyun-Jun Jang ,
Mingon Kang , Pann-Ghill Suh, and Jae-Yeol Joo* Prediction of
Alzheimer's disease specific phospholipase c gamma-1 SNV by deep
learning based approach for high-throughput screening. Proc. Natl. Acad.
Sci. U.S.A. Jan 19: 118(3) e2011250118 (2021). *Corresponding author
- Sumin Yang+, Key-Hwan Lim+, Sung-Hyun Kim, and Jae-Yeol Joo* Molecular
landscape of long noncoding RNAs in brain disorders. Molecular
Psychiatry Apr;26(4):1060-1074(2021). *Corresponding author
- Sung-Hyun Kim+, Key-Hwan Lim+, Sumin Yang, and Jae-Yeol Joo* Long
non-coding RNAs in brain tumors: Roles and potential as therapeutic
targets. Journal of Hematology & Oncology May 12; 14(1):77 (2021).
*Corresponding author
- Key-Hwan Lim, Sumin Yang, Sung-Hyun Kim, and Jae-Yeol Joo* Elevation of Ace2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease. Journal of Infection Jun 30:S0163-4453(20)30453-9. doi: 10.1016/j.jinf.2020.06.072.(2020) *Corresponding author
- Key-Hwan
Lim+, Sumin Yang+, Sung-Hyun
Kim+, Euiseong Ko, Mingon Kang, and Jae-Yeol Joo* Cryptic
mutation in phospholipase C of brain disorders: up-to-date discoveries and deep-learning-based
approach. Brain. Apr 19;146(4):1267-1280. doi: 10.1093/brain/awac451. (2023). *Corresponding author
- Sumin Yang+, Sung-Hyun Kim+, Eunjeong Yang, Mingon Kang, and Jae-Yeol Joo* Molecular insights of regulatory RNA in cellular machinery. Experimental & Molecular Medicine. Jun 14; 56(6):1235-1249. https://doi.org/10.1038/s12276-024-01239-6 (2024). *Corresponding author
Publications
- Jung-Mi Oh, HyunHo Yoon, Jae-Yeol Joo, Wan-Taek Im and Sungkun Chun. Therapeutic Potential of Ginseng Leaf Extract in Inhibiting Mast Cell-Mediated Allergic Inflammation and Atopic dermatitis-like skin inflammation in DNCB-Treated Mice.
- Frontiers in Pharmacology. May 22; 15:1403285. doi: 10.3389/fphar.2024.1403285 (2024)
- Sung-Hyun Kim+, Sumin Yang+, Eunjeong Yang, Mingon Kang, and Jae-Yeol Joo* Potent of strategic approaches for tauopathies ranging from single cell
transcriptome to microbiome.
- Animal Cells and Systems. Nov 27; 27(1):378-393. doi.10.1080/19768354.2023.2285826 (2023) *Corresponding author
- Sumin Yang+, Sung-Hyun Kim+, Mingon Kang, and Jae-Yeol Joo* Harnessing deep learning into hidden mutations of neurological disorders for therapeutic challenges.
- Archives of Pharmacal Research. Jun 1;46:535-549 doi: 10.1007/s12272-023-01450-5. (2023) *Corresponding author 07/s12272-023-01450-5. (2023) *Corresponding authorpages doi: 10.1007/s12272-023-01450-5. (2023) *Corresponding authorpages doi: 10.1007/s12272-023-01450-5. (2023) *Corresponding author
- Sung-Hyun Kim+, Key-Hwan Lim+, Sumin Yang+, and
Jae-Yeol Joo* Boosting of
tau protein aggregation by CD40 and CD48 gene expression in Alzheimer's disease.
- FASEB Journal. Jan;37(1):e22702. doi: 10.1096/fj.202201197R. (2023) *Corresponding author
- Jae-Yeol Joo*, Key-Hwan Lim, Sumin Yang, Sung-Hyun Kim, Lucio Cocco, and
Pann-Ghill Suh* Prediction of genetic alteration of Phospholipase C
Isozymes in Brain disorders: Studies with deep learning
- Adv. Biol.
Regul. Dec 1; (82):100833 (2021). *Co-corresponding author
- Key-Hwan Lim+, Sumin Yang+, Sung-Hyun Kim, and Jae-Yeol Joo* Identifying
new COVID-19 receptor Neuropilin-1 in severe Alzheimer’s diseases
patients group brain using genome-wide association study approach.
- Frontiers in Genetics Oct 21:12:741175. doi: 10.3389/fgene.2021.741175. (2021). *Corresponding
author
- Key-Hwan Lim+, Sung-Hyun Kim+, Sumin Yang+, Sungkun Chun, and Jae-Yeol
Joo* Advances in multiplex PCR for Alzheimer's disease diagnostics
targeting CDK genes.
- Neuroscience Letters Apr 1;749:135715
(2021). *Corresponding author
- Key-Hwan Lim, Sumin Yang+, Sung-Hyun Kim+, Sungkun Chun, and Jae-Yeol
Joo* Discoveries for long non-coding RNA dynamics in traumatic brain
injury.
- Biology Dec 10: 9(12), 458 (2020). *Corresponding author
- Key-Hwan Lim, and Jae-Yeol Joo* Predictive Potential of Circulating
Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or
Treatment of Alzheimer's Disease
- Int. J. Mol. Sci. May 11: 21(9): 3398
(2020). *Corresponding author
- Key-Hwan Lim, Jae-Yeol Joo, and Kwang-Hyun Baek The potential roles of
deubiquitinating enzymes in brain disease.
- Ageing Research Reviews May
26: doi: 10.1016/j.arr.2020.101088. (2020)
- Katie Schaukowitch*, Jae-Yeol Joo*, and Tae-Kyung Kim UV-RNA
Immunoprecipitation(UV-RIP) Protocol in Neurons.
- Method`s in Molecular
Biology.1468:33-38(2017). *Equal contribution (Invited)
- Katie Schaukowitch, Austin Reese, Seung-Kyoon Kim, Gokhul Kilaru,
Jae-Yeol Joo, Ege Kavalali, and Tae-Kyung Kim An intrinsic
transcriptional program underlying synaptic scaling during activity
suppression.
- Cell Reports.18(6):1512-1526 (2017)
- Parkyong Song, Yonghoon Kwon, Jae-Yeol Joo, Do-Geun Kim, and Jong Hyuk
Yoon Secretomics to Discover Regulators In Diseases
- Int. J. Mol.
Sci. 20(16): 3893 (2019)
- Misato Yasumura, Tomoyuki Yoshida, Sung-Jin Lee, Takeshi Uemura,
Jae-Yeol Joo, and Masayoshi Mishina. Glutamate receptor δ1 induces
preferentially inhibitory presynaptic differentiation of cortical
neurons by interacting with neurexinsthrough cerebellinprecursor protein
(Cbln) subtypes.
- Journal of Neurochem. 121(5):705-16 (2012)
- Jae-Yeol Joo*, Sung-Jin Lee*, Takeshi Uemura*, Tomoyuki Yoshida, Misato
Yasumura, Masahiko Watanabe, and Masayoshi Mishina. Differential
Interactions of Cerebellin Precursor Protein (Cbln) Subtypes and
Neurexin Variants for Synapse Formation of Cortical Neurons.
- Biochem.
Biophys. Res. Commun. 406(4):627-32(2011). *Co-first author
- Jae-Yeol Joo*, Byung-Woo Kim*, Jeong-Sik Lee*,Jin-Yong Park, Sunoh Kim,
Young-Joo Yun, Sang-Hun Lee, Suk-Ho Lee, Hye whon Rhim, and Hyeon Son.
Activation of NMDA receptors increases proliferation and differentiation
of hippocampal neural progenitorcells.
- Journal of Cell
Science.120(Pt8):1358-70(2007). *Co-first author
- Jong Bin Kim*, Jae-Yeol Joo*, Ju Hee Kim, Think-You Kim, Byung-Hwan
Yang, Yong-Sung Lee, and Hyeon Son. Dexamethasone inhibits proliferation
of adult hippocampal neurogenesis in vivo and in vitro.
- Brain
Res.1027(1-2):1-10(2004). *Co-first author
Patents
- 알츠하이머 질환의 진단 또는 치료를 위한 Ube2h의 용도 Use of Ube2h
for Diagnosis or Treatment of Alzheimer’s Disease Patent Number
10-2202120
- 알츠하이머 질환의 진단을 위한 Eef1a1의 용도 Use of Eef1a1 for
Diagnosis of Alzheimer's Disease Patent Number 10-2349630
- 알츠하이머 질환의 진단 또는 치료를 위한 SCARNA13의 용도 Use of
SCARNA13 for Diagnosis or Treatment of Alzheimer's Disease Application
Number 10-2349630
- 멀티플렉스 PCR 플랫폼 기반의 알츠하이머 질환 진단을 위한 신규한 마커
조성물 및 이의 용도 Novel biomarker composition for diagnosis of
Alzheimer's Disease based on multiplex PCR platform Application Number
10-2020-0105229